title: [Psoriasis arthropathica].
abstract: BACKGROUND
  Five to seven percent of patients with psoriasis suffer additionally from accompanying arthritis.
  
  
  OBJECTIVE
  In this article, we review the current knowledge on clinical, diagnostic and therapeutic aspects of the disease.
  
  
  RESULTS
  Data are presented on the treatment of six patients with the immunosuppressant ciclosporin. Therapeutic results with this drug are superior to agents traditionally used for management of psoriatic arthritis.
  
  
  CONCLUSIONS
  The therapeutic options have been enlarged by the introduction of new immunosuppressive drugs, particularly ciclosporin.
authors.affiliation: Cliniques Dermatologiques, l'Université Louis-Maximilien de Munich, Allemagne.
authors.forename: T
authors.initials: T
authors.lastname: Ruzicka
authors.forename: P
authors.initials: P
authors.lastname: Arenberger
authors.forename: S
authors.initials: S
authors.lastname: Wagner
authors.forename: R U
authors.initials: RU
authors.lastname: Peter
authors.forename: L
authors.initials: L
authors.lastname: Kemeny
mesh_terms: D000293:Adolescent; D000328:Adult; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006229:Hand Dermatoses / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D012446:Sacroiliac Joint; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D016572:Cyclosporine
vernacular_title: Psoriasis arthropathique.